Cargando…

Concordance Among 10 Different Anticholinergic Burden Scales in At-Risk Older Populations

The aim of the study was to evaluate the concordance among 10 anticholinergic scales for the measurement of anticholinergic drug exposure in at-risk elderly complex chronic patients in primary care. METHODS: An 8-month cross-sectional, multicenter study was carried out in a cohort of complex chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tristancho-Pérez, Ángela, Villalba-Moreno, Ángela, Santos-Rubio, María Dolores, Belda-Rustarazo, Susana, Santos-Ramos, Bernardo, Sánchez-Fidalgo, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162063/
https://www.ncbi.nlm.nih.gov/pubmed/34693926
http://dx.doi.org/10.1097/PTS.0000000000000929
_version_ 1784719620439015424
author Tristancho-Pérez, Ángela
Villalba-Moreno, Ángela
Santos-Rubio, María Dolores
Belda-Rustarazo, Susana
Santos-Ramos, Bernardo
Sánchez-Fidalgo, Susana
author_facet Tristancho-Pérez, Ángela
Villalba-Moreno, Ángela
Santos-Rubio, María Dolores
Belda-Rustarazo, Susana
Santos-Ramos, Bernardo
Sánchez-Fidalgo, Susana
author_sort Tristancho-Pérez, Ángela
collection PubMed
description The aim of the study was to evaluate the concordance among 10 anticholinergic scales for the measurement of anticholinergic drug exposure in at-risk elderly complex chronic patients in primary care. METHODS: An 8-month cross-sectional, multicenter study was carried out in a cohort of complex chronic patients older than 65 years in treatment with at least 1 drug with anticholinergic activity. Demographic, pharmacological, and clinical data were collected. Anticholinergic burden and risk were detected using the 10 scales included on the anticholinergic burden calculator (http://www.anticholinergicscales.es/). We used κ statistics to evaluated the concordance 2 to 2 (according to risk: high, medium, low or without risk) among the included scales. RESULTS: Four hundred seventy-three patients were recruited (60.3% female, median age of 84 years [interquartile range = 10]). Eighty was the total number of anticholinergic drugs with any scale (1197 prescriptions), with a median of 2 drugs with anticholinergic activity per patient (interquartile range = 2). The κ statistics comparing all the 10 scales ranged from −0.175 (Drug Burden Index versus Chew Scale) to 0.708 (Anticholinergic Activity Scale [AAS] versus Chew Scale). The best concordance was obtained between AAS and Chew Scale (κ = 0.708), followed by Clinician-Rated Anticholinergic Scale and Duran Scale (κ = 0.632) and AAS and Anticholinergic Cognitive Burden Scale (κ = 0.618), being considered substantial strengths of concordance. CONCLUSIONS: The agreement among the 10 scales in elderly patients with complex chronic conditions was highly variable. Great care should be taken when assessing anticholinergic drug exposure using existing scales because of the wide variability among them. The only scales that showed agreement were the AAS-Chew, Clinician-Rated Anticholinergic Scale–Duran, and AAS–Anticholinergic Cognitive Burden Scale pairs. In the rest of the cases, the scales are not interchangeable.
format Online
Article
Text
id pubmed-9162063
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-91620632022-06-08 Concordance Among 10 Different Anticholinergic Burden Scales in At-Risk Older Populations Tristancho-Pérez, Ángela Villalba-Moreno, Ángela Santos-Rubio, María Dolores Belda-Rustarazo, Susana Santos-Ramos, Bernardo Sánchez-Fidalgo, Susana J Patient Saf Original Studies The aim of the study was to evaluate the concordance among 10 anticholinergic scales for the measurement of anticholinergic drug exposure in at-risk elderly complex chronic patients in primary care. METHODS: An 8-month cross-sectional, multicenter study was carried out in a cohort of complex chronic patients older than 65 years in treatment with at least 1 drug with anticholinergic activity. Demographic, pharmacological, and clinical data were collected. Anticholinergic burden and risk were detected using the 10 scales included on the anticholinergic burden calculator (http://www.anticholinergicscales.es/). We used κ statistics to evaluated the concordance 2 to 2 (according to risk: high, medium, low or without risk) among the included scales. RESULTS: Four hundred seventy-three patients were recruited (60.3% female, median age of 84 years [interquartile range = 10]). Eighty was the total number of anticholinergic drugs with any scale (1197 prescriptions), with a median of 2 drugs with anticholinergic activity per patient (interquartile range = 2). The κ statistics comparing all the 10 scales ranged from −0.175 (Drug Burden Index versus Chew Scale) to 0.708 (Anticholinergic Activity Scale [AAS] versus Chew Scale). The best concordance was obtained between AAS and Chew Scale (κ = 0.708), followed by Clinician-Rated Anticholinergic Scale and Duran Scale (κ = 0.632) and AAS and Anticholinergic Cognitive Burden Scale (κ = 0.618), being considered substantial strengths of concordance. CONCLUSIONS: The agreement among the 10 scales in elderly patients with complex chronic conditions was highly variable. Great care should be taken when assessing anticholinergic drug exposure using existing scales because of the wide variability among them. The only scales that showed agreement were the AAS-Chew, Clinician-Rated Anticholinergic Scale–Duran, and AAS–Anticholinergic Cognitive Burden Scale pairs. In the rest of the cases, the scales are not interchangeable. Lippincott Williams & Wilkins 2022-06 2021-10-22 /pmc/articles/PMC9162063/ /pubmed/34693926 http://dx.doi.org/10.1097/PTS.0000000000000929 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Studies
Tristancho-Pérez, Ángela
Villalba-Moreno, Ángela
Santos-Rubio, María Dolores
Belda-Rustarazo, Susana
Santos-Ramos, Bernardo
Sánchez-Fidalgo, Susana
Concordance Among 10 Different Anticholinergic Burden Scales in At-Risk Older Populations
title Concordance Among 10 Different Anticholinergic Burden Scales in At-Risk Older Populations
title_full Concordance Among 10 Different Anticholinergic Burden Scales in At-Risk Older Populations
title_fullStr Concordance Among 10 Different Anticholinergic Burden Scales in At-Risk Older Populations
title_full_unstemmed Concordance Among 10 Different Anticholinergic Burden Scales in At-Risk Older Populations
title_short Concordance Among 10 Different Anticholinergic Burden Scales in At-Risk Older Populations
title_sort concordance among 10 different anticholinergic burden scales in at-risk older populations
topic Original Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162063/
https://www.ncbi.nlm.nih.gov/pubmed/34693926
http://dx.doi.org/10.1097/PTS.0000000000000929
work_keys_str_mv AT tristanchoperezangela concordanceamong10differentanticholinergicburdenscalesinatriskolderpopulations
AT villalbamorenoangela concordanceamong10differentanticholinergicburdenscalesinatriskolderpopulations
AT santosrubiomariadolores concordanceamong10differentanticholinergicburdenscalesinatriskolderpopulations
AT beldarustarazosusana concordanceamong10differentanticholinergicburdenscalesinatriskolderpopulations
AT santosramosbernardo concordanceamong10differentanticholinergicburdenscalesinatriskolderpopulations
AT sanchezfidalgosusana concordanceamong10differentanticholinergicburdenscalesinatriskolderpopulations